These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29905793)

  • 1. Yeast as a model to study protein misfolding in aged cells.
    Di Gregorio SE; Duennwald ML
    FEMS Yeast Res; 2018 Sep; 18(6):. PubMed ID: 29905793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring polyglutamine toxicity in yeast.
    Duennwald ML
    Methods; 2011 Mar; 53(3):232-7. PubMed ID: 21144902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the power of yeast to model aging and age-related neurodegenerative disorders.
    Oliveira AV; Vilaça R; Santos CN; Costa V; Menezes R
    Biogerontology; 2017 Feb; 18(1):3-34. PubMed ID: 27804052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yeast models of neurodegenerative diseases.
    Tuite MF
    Prog Mol Biol Transl Sci; 2019; 168():351-379. PubMed ID: 31699326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural studies on the mechanism of protein aggregation in age related neurodegenerative diseases.
    Eftekharzadeh B; Hyman BT; Wegmann S
    Mech Ageing Dev; 2016 Jun; 156():1-13. PubMed ID: 27005270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing the power of yeast to unravel the molecular basis of neurodegeneration.
    Tenreiro S; Munder MC; Alberti S; Outeiro TF
    J Neurochem; 2013 Nov; 127(4):438-52. PubMed ID: 23600759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yeast as a platform to explore polyglutamine toxicity and aggregation.
    Duennwald ML
    Methods Mol Biol; 2013; 1017():153-61. PubMed ID: 23719914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yeast as a model for studying human neurodegenerative disorders.
    Miller-Fleming L; Giorgini F; Outeiro TF
    Biotechnol J; 2008 Mar; 3(3):325-38. PubMed ID: 18228539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurodegenerative amyloidoses: the yeast model].
    Vishnevskaia AB; Kushnirov VV; Ter-Avanesian MD
    Mol Biol (Mosk); 2007; 41(2):346-54. PubMed ID: 17514901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The stationary phase model of aging in yeast for the study of oxidative stress and age-related neurodegeneration.
    Chen Q; Ding Q; Keller JN
    Biogerontology; 2005; 6(1):1-13. PubMed ID: 15834659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Misfolding-prone proteins are reversibly sequestered to an Hsp42-associated granule upon chronological aging.
    Lee HY; Chao JC; Cheng KY; Leu JY
    J Cell Sci; 2018 Aug; 131(16):. PubMed ID: 30054385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyglutamine misfolding in yeast: toxic and protective aggregation.
    Duennwald ML
    Prion; 2011; 5(4):285-90. PubMed ID: 22052348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AAA+ Protein-Based Technologies to Counter Neurodegenerative Disease.
    March ZM; Mack KL; Shorter J
    Biophys J; 2019 Apr; 116(8):1380-1385. PubMed ID: 30952364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yeast Models and Molecular Mechanisms of Neurodegenerative Diseases.
    Kaminska J; Zoladek T
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yeast cells reveal the misfolding and the cellular mislocalization of the human BRCA1 protein.
    Thouvenot P; Fourrière L; Dardillac E; Ben Yamin B; Lescure A; Lejour V; Heiligenstein X; Boulé JB; Romao M; Raposo-Benedetti G; Lopez BS; Nicolas A; Millot GA
    J Cell Sci; 2016 Dec; 129(23):4366-4378. PubMed ID: 27802165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein misfolding in the late-onset neurodegenerative diseases: common themes and the unique case of amyotrophic lateral sclerosis.
    Mulligan VK; Chakrabartty A
    Proteins; 2013 Aug; 81(8):1285-303. PubMed ID: 23508986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetics approaches in yeast to study amyloid diseases.
    Outeiro TF; Muchowski PJ
    J Mol Neurosci; 2004; 23(1-2):49-60. PubMed ID: 15126692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein aggregation into insoluble deposits protects from oxidative stress.
    Carija A; Navarro S; de Groot NS; Ventura S
    Redox Biol; 2017 Aug; 12():699-711. PubMed ID: 28410533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglia and the aging brain: are senescent microglia the key to neurodegeneration?
    Angelova DM; Brown DR
    J Neurochem; 2019 Dec; 151(6):676-688. PubMed ID: 31478208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
    Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
    Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.